Lymphoma 2006: classification and treatment.
The past 20 years have brought significant advances in our ability to manage patients with non-Hodgkin's lymphoma. More precise classification systems, improvements in diagnosis and staging, and effective new treatments have improved outcomes and made cure a reasonable goal for many patients with these disorders. In this overview of the progress seen in the field over the past 2 decades, we describe a variety of advances for specific lymphomas, including diagnostic methods such as gene array studies and immunophenotyping and new treatment approaches.
Armitage
James O
JO
Section of Oncology/Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198, USA. joarmita@unmc.edu
Bierman
Philip J
PJ
Bociek
R Gregory
RG
Vose
Julie M
JM
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D016130:Immunophenotyping; D008228:Lymphoma, Non-Hodgkin / Q000145:classification / Q000188:drug therapy*; D009367:Neoplasm Staging; D014178:Translocation, Genetic; D016896:Treatment Outcome